Stay updated on Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new NIH-wide notice announces website-transition updates and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence.” The study page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-24T15:59:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.1 to v3.7.2. The study record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:55:11.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision indicator changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:48:54.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with an access-restricted message. This indicates an access issue rather than an update to the study record.
    Difference
    18%
    Check dated 2026-09-19T18:10:25.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, reflecting a software revision on the page with no changes to study content or user-facing details.
    Difference
    0.1%
    Check dated 2026-08-29T21:48:28.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 indicating a minor site update to the page. This change does not modify study data, eligibility criteria, or the published details of the trial.
    Difference
    0.1%
    Check dated 2026-08-08T20:13:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.